Recent Investment Analysts’ Ratings Changes for Bowhead Specialty (BOW)

Bowhead Specialty (NYSE: BOW) recently received a number of ratings updates from brokerages and research firms:

• 5/26/2026 – Bowhead Specialty was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
• 5/26/2026 – Bowhead Specialty had its price target raised by Piper Sandler from $28.00 to $32.00. They now have an “overweight” rating on the stock.
• 5/21/2026 – Bowhead Specialty was given a new $28.00 price target by UBS Group AG.
• 5/21/2026 – Bowhead Specialty had its price target raised by Morgan Stanley from $27.00 to $28.00. They now have an “equal weight” rating on the stock.
• 5/13/2026 – Bowhead Specialty had its price target raised by Keefe, Bruyette & Woods from $31.00 to $34.00. They now have an “outperform” rating on the stock.
• 5/12/2026 – Bowhead Specialty had its price target raised by Morgan Stanley from $25.00 to $27.00. They now have an “equal weight” rating on the stock.
• 5/8/2026 – Bowhead Specialty was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 4/13/2026 – Bowhead Specialty had its price target lowered by Citizens Jmp from $38.00 to $35.00. They now have a “market outperform” rating on the stock.
• 4/6/2026 – Bowhead Specialty had its price target lowered by Morgan Stanley from $27.00 to $25.00. They now have an “equal weight” rating on the stock.

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.